Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8776 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD2534 |
Approved |
0.8649 |
High Similarity |
NPD2533 |
Approved |
0.8649 |
High Similarity |
NPD2532 |
Approved |
0.8636 |
High Similarity |
NPD7075 |
Discontinued |
0.8562 |
High Similarity |
NPD2800 |
Approved |
0.8562 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8531 |
High Similarity |
NPD6651 |
Approved |
0.8506 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8493 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8442 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8442 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8425 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8367 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8356 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8333 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8311 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8289 |
Intermediate Similarity |
NPD920 |
Approved |
0.8288 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.828 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8212 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8158 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8138 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8027 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8013 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7974 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7963 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7963 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7927 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7892 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7879 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7866 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7844 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7826 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7806 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7751 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7751 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7692 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7682 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7682 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7635 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7368 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7343 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7321 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7299 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7297 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7297 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7285 |
Intermediate Similarity |
NPD411 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD2798 |
Approved |
0.723 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7203 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7166 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7152 |
Intermediate Similarity |
NPD37 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7117 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7108 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7095 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD943 |
Approved |
0.7069 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7007 |
Intermediate Similarity |
NPD17 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6984 |
Remote Similarity |
NPD7583 |
Approved |
0.6983 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6977 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD1613 |
Approved |
0.6968 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4477 |
Approved |
0.6962 |
Remote Similarity |
NPD4476 |
Approved |
0.6962 |
Remote Similarity |
NPD5408 |
Approved |
0.6962 |
Remote Similarity |
NPD5404 |
Approved |
0.6962 |
Remote Similarity |
NPD5406 |
Approved |
0.6962 |
Remote Similarity |
NPD5405 |
Approved |
0.6954 |
Remote Similarity |
NPD1164 |
Approved |
0.6954 |
Remote Similarity |
NPD7228 |
Approved |
0.6946 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6941 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4749 |
Approved |
0.6928 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6927 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD1933 |
Approved |
0.6915 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6908
|
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |